Eyepoint Pharmaceuticals, Inc.
Clinical trials sponsored by Eyepoint Pharmaceuticals, Inc., explained in plain language.
-
New eye drug could reduce shots for Diabetes-Related vision loss
Disease control Recruiting nowThis study tests a new medicine called EYP-1901 against a standard treatment (aflibercept) for people with diabetic macular edema, a condition that causes vision loss in people with diabetes. About 240 participants will receive either the new drug or the standard one, and researc…
Phase: PHASE3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 09:54 UTC
-
New eye drug could mean fewer shots for Diabetes-Related vision loss
Disease control Recruiting nowThis study tests a new medicine called EYP-1901 against a standard treatment (aflibercept) for people with diabetic macular edema, a condition that causes blurry vision due to diabetes. About 240 adults will receive either the new drug or the standard one, and researchers will ch…
Phase: PHASE3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC